Bioequivalence and pharmacokinetics of 70 mg alendronate sodium tablets by measuring alendronate in plasma

Archives of Pharmacal Research

Volumn 29, Issue 4, 2006, Pages 328-332

  Yun, Min Hyuk ^a   Woo, Jong Su ^b   Kwon, Kwang Il ^a  

^a Chungnam National University   (South Korea)

^b Hanmi Pharmaceutical Co Ltd   (South Korea)

Author keywords

Alendronate; Bioequivalence; HPLC FD; Human plasma; Pharmacokinetics

Indexed keywords

EID: 33646390686     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02968579     Document Type: Article

References (9)

1. Astrom, E. and Soderhall S., Beneficial effect of bisphosphonate during five years of treatment of severe osteogenesis imperfecta. Acta. Paediatr., 87, 64-68 (1998).
2. Kang, W. K., Yun, H. Y., and Kwon, K. I., Assessing the bioequivalence of 4- and 8-mg benidipine tablets in healthy volunteers after a single oral dose. J. Clin. Pharm. Ther., 30, 85-90 (2005).
3. Lane, J. M., Khan, S. N., O'Connor, W. J., Nydick, M., Hommen, J. P., and Schneider, R., Bisphosphonate therapy in fibrous dysplasia. Clin. Orthop., 6-12 (2001).
4. Liberman, U. A., Weiss, S. R., Broll, J., Minne, H. W., Quan, H., and Bell, N. H., Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N. Engl. J. Med., 333, 1437-1443 (1995).
5. Lin, J. H., Bisphosphonates: A review of their pharmacokinetic properties. Bone, 18, 75-85 (1996).
6. Rodan, G. A. and Martin, T. J., Therapeutic approaches to bone diseases. Science, 289, 1508-1508 (2000).
7. Sato, M., Grasser, W., Endo, N., Akins, R., Simmons, H., and Thompson, D. D., Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. J. Clin. Invest., 88, 2095-2105 (1991).
8. Schmidt, A., Rutledge, S. J., Endo, N., Opas, E. E., Tanaka, H., and Wesolowski, G., Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate. Proc. Nat. Acad. Sci. U.S.A., 93, 3068-3073 (1996).
9. Yun, M. H. and Kwon K. I., High-performance liquid chromatography method for determining alendronate sodium in human plasma by detecting fluorescence: Application to a pharmacokinetic study in humans. J. Pharm. Biomed. Anal., in press (2005).